Vestmark Advisory Solutions Inc. Makes New $483,000 Investment in Lam Research Corporation $LRCX

Vestmark Advisory Solutions Inc. purchased a new stake in Lam Research Corporation (NASDAQ:LRCX) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 4,962 shares of the semiconductor company’s stock, valued at approximately $483,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC increased its position in shares of Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after purchasing an additional 12,936 shares in the last quarter. Mutual of America Capital Management LLC purchased a new position in Lam Research during the 1st quarter worth $13,345,000. Stephens Inc. AR increased its position in Lam Research by 55.0% during the 1st quarter. Stephens Inc. AR now owns 9,603 shares of the semiconductor company’s stock valued at $698,000 after buying an additional 3,409 shares in the last quarter. CWM LLC raised its stake in Lam Research by 32.0% in the first quarter. CWM LLC now owns 66,123 shares of the semiconductor company’s stock valued at $4,807,000 after buying an additional 16,028 shares during the last quarter. Finally, Bleakley Financial Group LLC boosted its holdings in Lam Research by 11.9% in the first quarter. Bleakley Financial Group LLC now owns 27,518 shares of the semiconductor company’s stock worth $2,001,000 after acquiring an additional 2,922 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insider Transactions at Lam Research

In other Lam Research news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 62,528 shares of company stock worth $8,880,448 over the last quarter. 0.31% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their price objective on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. New Street Research boosted their target price on shares of Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Evercore ISI upped their price target on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the stock an “equal weight” rating in a research note on Monday, October 20th. Finally, Raymond James Financial upped their target price on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Lam Research presently has an average rating of “Moderate Buy” and an average target price of $148.54.

Lam Research Stock Down 4.3%

LRCX stock opened at $159.18 on Wednesday. The company has a market capitalization of $199.93 billion, a P/E ratio of 35.06, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $167.15. The firm’s fifty day simple moving average is $137.51 and its 200-day simple moving average is $108.19. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the previous year, the firm posted $0.86 earnings per share. The firm’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s payout ratio is 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.